This finding is similar to the results of a previous retrospective study of infants with new-onset IESS comparing 13 infants treated with KDT to 20 infants treated with ACTH, In this retrospective study, the KDT was observed to have a nearly two-thirds success rate in stopping spasms, with fewer adverse effects and relapse rates than ACTH. This evidence concerns the gene POMC and infantile spasms.